More Globe Newswire

View Older Stories View Newer Stories

Nov 4, 2024 05:00AM Statkraft AS: Release of third quarter results 2024
Nov 4, 2024 05:00AM Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
Nov 4, 2024 04:54AM Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
Nov 4, 2024 04:52AM Dimensional Fund Advisors Ltd. : Form 8.3 - CENTAMIN PLC - Ordinary Shares
Nov 4, 2024 04:48AM HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
Nov 4, 2024 04:48AM Man Group PLC : Form 8.3 - TI Fluid Systems plc
Nov 4, 2024 04:44AM Man Group PLC : Form 8.3 - Smith (DS) plc
Nov 4, 2024 04:41AM Man Group PLC : Form 8.3 - International Paper Company
Nov 4, 2024 04:39AM Change to the Board
Nov 4, 2024 04:30AM Landsbankinn hf.: Offering of covered bonds
Nov 4, 2024 04:30AM VR Resources Augments Non-Brokered Private Placement with Flow Through Component
Nov 4, 2024 04:30AM Metasphere Updates on Strategic Projects and Plans for Future Developments
Nov 4, 2024 04:30AM SHARE BUYBACK TRANSACTIONS
Nov 4, 2024 04:30AM KH Group’s financial information and Annual General Meeting in 2025
Nov 4, 2024 04:23AM From Customer Appreciation to Industry Recognition: WIN SOURCE Takes the Crown at the Service Excellence Award
Nov 4, 2024 04:17AM HEROWORKS Embarks on Global Expansion with Hotel Revenue Management System
Nov 4, 2024 04:15AM Danske Bank share buy-back programme: Transactions in week 44
Nov 4, 2024 04:09AM Sydbank share buyback programme: transactions in week 44
Nov 4, 2024 04:07AM Trading by management and close relations of management
Nov 4, 2024 04:02AM Heimar hf.: Regular Notification of Share Buybacks in Accordance with the Buyback Program
Nov 4, 2024 04:00AM Data Storage Corporation Provides Letter to Shareholders Highlighting Recent Achievements within CloudFirst Technologies Subsidiary
Nov 4, 2024 04:00AM Tessellate BIO Announces Appointment of Lara Boyd as Chief Business Officer
Nov 4, 2024 03:38AM DIGZAX Enhances Collaborative Security System, Pioneering New Heights in Cryptocurrency Trading
Nov 4, 2024 03:30AM Alm. Brand A/S – Weekly report on share buybacks
Nov 4, 2024 03:26AM Form 8.5 (EPT/RI) - Brown (N) Group Plc
Nov 4, 2024 03:24AM Form 8.5 (EPT/RI) - NewRiver REIT Plc
Nov 4, 2024 03:18AM Prepayments (CK93) - Totalkredit A/S
Nov 4, 2024 03:18AM Prepayments (CK93) - Nykredit Realkredit A/S
Nov 4, 2024 03:05AM Share buyback programme - week 44
Nov 4, 2024 03:00AM Nokia signs 5G deal extension with Taiwan Mobile
Nov 4, 2024 03:00AM Treatment.com AI Announces Release of New Medical Education Suite (MES) and Update on the AI Assessment Symposium 1st November, 2024
Nov 4, 2024 03:00AM Municipality Finance issues EUR 20 million notes under its MTN programme
Nov 4, 2024 03:00AM 4BIO Capital Strengthens Investment Team
Nov 4, 2024 03:00AM 18th Global Citizenship Conference to be held in Singapore
Nov 4, 2024 02:48AM Preliminary data on early redemptions (prepayments)
Nov 4, 2024 02:30AM Innofactor Plc: Managers’ Transactions
Nov 4, 2024 02:30AM The road ahead – Terranet's product development plan for BlincVision 2025
Nov 4, 2024 02:10AM Exor Press Release - Periodic Report on the Buyback Program
Nov 4, 2024 02:00AM Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Nov 4, 2024 02:00AM Caledonia Mining Corporation Plc: Notice of Results and Investor Presentation
Nov 4, 2024 02:00AM Aktsiaselts Infortar Unaudited Consolidated Interim Report for third quarter of 2024
Nov 4, 2024 02:00AM Transaction in own shares
Nov 4, 2024 02:00AM Subsea7 share repurchases
Nov 4, 2024 02:00AM RCS Business Messaging Traffic to Grow 50% in 2025
Nov 4, 2024 01:40AM Bureau Veritas strengthens its Buildings & Infrastructure leadership position in Asia-Pacific with an agreement to acquire The APP Group
Nov 4, 2024 01:30AM QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Nov 4, 2024 01:30AM BW Energy Limited: First day of trading of bonds
Nov 4, 2024 01:30AM Sampo plc’s share buybacks 1 November 2024
Nov 4, 2024 01:30AM OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis
Nov 4, 2024 01:00AM Start of Day Message
View Newer Stories View Older Stories